Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa

Journal of Psychiatric Research

Volumn 45, Issue 5, 2011, Pages 706-711

  Müller, Timo D ^a   Tschöp, Matthias H ^a   Jarick, Ivonne ^b   Ehrlich, Stefan ^c   Scherag, Susann ^d   Herpertz Dahlmann, Beate ^e   Zipfel, Stefan ^f   Herzog, Wolfgang ^g   de Zwaan, Martina ^h   Burghardt, Roland ⁱ   Fleischhaker, Christian ^j   Klampfl, Karin ^k   Wewetzer, Christoph ^l   Herpertz, Stephan ^m   Zeeck, Almut ^j   Tagay, Sefik ⁿ   Burgmer, Markus ^o   Pfluger, Paul T ^a   Scherag, André ^d   Hebebrand, Johannes ^d   Hinney, Anke ^d   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF FREIBURG   (Germany)

^k UNIVERSITY OF WÜRZBURG   (Germany)

^l UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^m RUHR UNIVERSITY BOCHUM   (Germany)

ⁿ UNIVERSITY HOSPITAL ESSEN   (Germany)

^o UNIVERSITY HOSPITAL MÜNSTER   (Germany)

more..

Author keywords

Anorexia nervosa; Association study; Ghrelin; GOAT

Indexed keywords

ADULT; ANOREXIA NERVOSA; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GHRELIN O ACYLTRANSFERASE GENE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ACYLTRANSFERASES; ANOREXIA NERVOSA; BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79955020763     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.10.001     Document Type: Article

References (68)

1. American Psychiatric Association Diagnostic and statistical manual 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Anders H.J., Rosenbauer J., Matiaske B. Repäsentative Verzehrstudie in der Bundesrepublik Deutschland inkl. West-Berlin. Zeitschriftenreihe der AGEV 1990, Bd. 8. Umschau Verlag, Frankfurt 1990.
3. Ando T., Ishikawa T., Kawamura N., Karibe M., Oba M., Tatsuta N., et al. Analysis of tumor necrosis factor-alpha gene promoter polymorphisms in anorexia nervosa. Psychiatric Genetics 2001, 11:161-164.
4. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955, 11:375-386.
5. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism 2001, 86:1169-1174.
6. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120:337-345.
7. Cellini E., Nacmias B., Brecelj-Anderluh M., Badía-Casanovas A., Bellodi L., Boni C., et al. EC framework V 'factors in healthy eating' consortium. Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatric Genetics 2006, 16:51-52.
8. Counts D.R., Gwirtsman H., Carlsson L.M., Lesem M., Cutler G.B. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. Journal of Clinical Endocrinology and Metabolism 1992, 75:762-767.
9. Dardennes R.M., Zizzari P., Tolle V., Foulon C., Kipman A., Romo L., et al. Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 2007, 32:106-113.
10. Druce M.R., Neary N.M., Small C.J., Milton J., Monteiro M., Patterson M., et al. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. International Journal of Obesity 2006, 30:293-296.
11. Friedel S., Horro F.F., Wermter A.K., Geller F., Dempfle A., Reichwald K., et al. Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2005, 132B:96-99.
12. Fuller S.J., Mynett J.R., Sugden P.H. Stimulation of cardiac protein synthesis by insulin-like growth factors. The Biochemical Journal 1992, 282(Pt 1):85-90.
13. Germain N., Galusca B., Grouselle D., Frere D., Tolle V., Zizzari P., et al. Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa. Psychoneuroendocrinology 2009, 34:413-419.
14. Germain N., Galusca B., Le Roux C.W., Bossu C., Ghatei M.A., Lang F., et al. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. American Journal of Clinical Nutrition 2007, 85:967-971.
15. Gorwood P., Kipman A., Foulon C. The human genetics of anorexia nervosa. European Journal of Pharmacology 2003, 480:163-170.
16. Gueorguiev M., Lecoeur C., Meyre D., Benzinou M., Mein C.A., Hinney A., et al. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity (Silver Spring) 2009, 17:745-754.
17. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6320-6325.
18. Hanaire-Broutin H., Sallerin-Caute B., Poncet M.F., Tauber M., Bastide R., Rosenfeld R., et al. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization. Diabetes & Metabolism 1996, 22:245-250.
19. Harada T., Nakahara T., Yasuhara D., Kojima S., Sagiyama K., Amitani H., et al. Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biological Psychiatry 2008, 63:245-257.
20. Hebebrand J., Heseker H., Himmelmann G.W., Schäfer H., Remschmidt H. Percentiles for the body mass index based on data of the German National Nutrition Survey and a review of relevant factors with an influence on body weight. Aktuelle Ernährungsmedizin 1994, 19:259-265.
21. Hebebrand J., Remschmidt H. Anorexia nervosa viewed as an extreme weight condition: genetic implications. Human Genetics 1995, 95:1-11.
22. Herpertz-Dahlmann B., Müller B., Herpertz S., Heussen N., Hebebrand J., Remschmidt H. Prospective 10-year follow-up in adolescent anorexia nervosa-course, outcome, psychiatric comorbidity, and psychosocial adaptation. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2001, 42:603-612.
23. Herpertz-Dahlmann B.M., Wewetzer C., Schulz E., Remschmidt H. Course and outcome in adolescent anorexia nervosa. International Journal of Eating Disorders 1996, 19:335-345.
24. Hinney A., Bettecken T., Tarnow P., Brumm H., Reichwald K., Lichtner P., et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. Clinics in Endocrinology and Metabolism 2006, 91:1761-1769.
25. Hinney A., Bornscheuer A., Depenbusch M., Mierke B., Tölle A., Middeke K., et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Molecular Psychiatry 1998, 3:539-543.
26. Hinney A., Friedel S., Remschmidt H., Hebebrand J. Genetic risk factors in eating disorders. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 2004, 4:209-223.
27. Hinney A., Ziegler A., Nöthen M.M., Remschmidt H., Hebebrand J. 5-HT2A receptor gene polymorphisms, anorexia nervosa, and obesity. Lancet 1997, 350:1324-1325.
28. Hoek H.W., van Hoeken D. Review of the prevalence and incidence of eating disorders. International Journal of Eating Disorders 2003, 34:383-396.
29. Hotta M., Ohwada R., Akamizu T., Shibasaki T., Takano K., Kangawa K. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocrine Journal 2009, 56:1119-1128.
30. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000, 141:4797-4800.
31. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 50:2438-2443.
32. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009, 15:741-745. Erratum in: Nature Medicine 2009;15:1093.
33. Klump K.L., Miller K.B., Keel P.K., McGue M., Iacono W.G. Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychological Medicine 2001, 31:737-740.
34. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
35. Milos G., Spindler A., Schnyder U., Fairburn C.G. Instability of eating disorder diagnoses: prospective study. British Journal of Psychiatry: The Journal of Mental Science 2005, 187:573-578.
36. Misra M., Miller K.K., Bjornson J., Hackman A., Aggarwal A., Chung J., et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. Journal of Clinical Endocrinology and Metabolism 2003, 88:5615-5623.
37. Miyasaka K., Hosoya H., Sekime A., Ohta M., Amono H., Matsushita S., et al. Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population. Journal of Neural Transmission 2006, 113:1279-1285.
38. Moller N., Vendelbo M.H., Kampmann U., Christensen B., Madsen M., Norrelund H., et al. Growth hormone and protein metabolism. Clinical Nutrition (Edinburgh, Scotland) 2009, 28:597-603.
39. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 2008, 93:4418-4421.
40. Monteleone P., Tortorella A., Castaldo E., Di Filippo C., Maj M. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa. Neuroscience Letters 2006, 398:325-327.
41. Monzavi R., Cohen P. IGFs and IGFBPs: role in health and disease. Best Practice & research. Clinical Endocrinology & Metabolism 2002, 16:433-447.
42. Müller T.D., Brönner G., Wandolski M., Carrie J., Nguyen T.T., Greene B.H., et al. Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity. BMC Medical Genetics 2010, 11:2.
43. Müller T.D., Hinney A., Scherag A., Nguyen T.T., Schreiner F., Schaefer H., et al. 'Fat mass and obesity associated' gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Medical Genetics 2008, 9:85.
44. Müller T.D., Reichwald K., Brönner G., Kirschner J., Nguyen T.T., Scherag A., et al. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child and Adolescent Psychiatry and Mental Health 2008, 2:33.
45. Nakahara T., Harada T., Yasuhara D., Shimada N., Amitani H., Sakoguchi T., et al. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biological Psychiatry 2008, 64:252-255.
46. Nakai Y., Hosoda H., Nin K., Ooya C., Hayashi H., Akamizu T., et al. Short-term secretory regulation of the active form of ghrelin and total ghrelin during an oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol 2004, 150:913-914. Erratum in: European Journal of Endocrinology 2005; 152:163.
47. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology 2001, 145:669-673.
48. Otto B., Tschöp M., Frühauf E., Heldwein W., Fichter M., Otto C., et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 2005, 30:577-581.
49. Pinheiro A.P., Sullivan P.F., Bacaltchuck J., Prado-Lima P.A., Bulik C.M. Genetics in eating disorders: extending the boundaries of research. Revista Brasileira de Psiquiatria 2006, 28:218-225.
50. Prince A.C., Brooks S.J., Stahl D., Treasure J. Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. American Journal of Clinical Nutrition 2009, 89:755-765.
51. Quinton N.D., Meechan D.W., Brown K., Eastwood H., Blakemore A.I. 2004 Single nucleotide polymorphisms in the leptin receptor gene: studies in anorexia nervosa. Psychiatric Genetics 2004, 14:191-194.
52. Ribasés M., Gratacòs M., Armengol L., de Cid R., Badía A., Jiménez L., et al. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Molecular Psychiatry 2003, 8:745-751.
53. Ribasés M., Gratacòs M., Fernández-Aranda F., Bellodi L., Boni C., Anderluh M., et al. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. European Journal of Human Genetics: EJHG 2005, 13:428-434.
54. Ribasés M., Gratacòs M., Fernández-Aranda F., Bellodi L., Boni C., Anderluh M., et al. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Human Molecular Genetics 2004, 13:1205-1212.
55. Scacchi M., Pincelli A.I., Caumo A., Tomasi P., Delitala G., Baldi G., et al. Spontaneous nocturnal growth hormone secretion in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 1997, 82:3225-3229.
56. Scherag S., Hebebrand J., Hinney A. Eating disorders: the current status of molecular genetic research. European Child & Adolescent Psychiatry 2010, 19:211-226.
57. Sulek S., Lacinová Z., Dolinková M., Haluzik M. Genetic polymorphisms as a risk factor for anorexia nervosa. Prague Medical Report 2007, 108:215-225.
58. Tolle V., Kadem M., Bluet-Pajot M.T., Frere D., Foulon C., Bossu C., et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. Journal of Clinical Endocrinology and Metabolism 2003, 88:109-116.
59. Tozzi F., Thornton L.M., Klump K.L., Fichter M.M., Halmi K.A., Kaplan A.S., et al. Symptom fluctuation in eating disorders: correlates of diagnostic crossover. The American Journal of Psychiatry 2005, 162:732-740.
60. Troisi A., Di Lorenzo G., Lega I., Tesauro M., Bertoli A., Leo R., et al. Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 2005, 81:259-266.
61. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
62. Vyver E., Steinegger C., Katzman D.K. Eating disorders and menstrual dysfunction in adolescents. Annals of the New York Academy of Sciences 2008, 1135:253-264.
63. Wigginton E., Cutler D., Abecasis G. A Note on exact tests of Hardy-Weinberg equilibrium. American Journal of Human Genetics 2005, 76:883-887.
64. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. The Journal of Clinical Endocrinology and Metabolism 2001, 86:5992-5995.
65. Yang J., Zhao T.J., Goldstein J.L., Brown M.S. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10750-10755.
66. Ye S., Dhillon S., Ke X., Collins A.R., Day I.N. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research 2001, 29:E88.
67. Zhao T.J., Liang G., Li R.L., Xie X., Sleeman M.W., Murphy A.J., et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proceedings of the National Academy of Sciences of the United States of America 2010 Mar 15, [Epub ahead of print].
68. Zipfel S., Löwe B., Reas D.L., Deter H.C., Herzog W. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet 2000, 355:721-722.